Are SERMs safe and effective for the treatment of hypogonadism in men?

Affiliations

Advocate Illinois Masonic Family Medicine Residency

Abstract

YES. For both normal-weight and obese men with low testosterone levels and hypogonadal symptoms, selective estrogen receptor modulators (SERMs), such as clomiphene citrate (CC) and enclomiphene citrate (EC), appear to be effective and safe for improving serum testosterone levels (strength of recommendation [SOR]: C, disease-oriented outcomes from randomized controlled trials [RCTs] and cohort studies). Studies also show that symptom improvement is comparable to that with exogenous testosterone replacement and similar to eugonadal men (SOR: B, patient-oriented outcomes from retrospective cohort studies).

Document Type

Article

PubMed ID

35259334

Teammate Access

Link to Full Text

 

Share

COinS